Accéder au contenu
Merck

USP Analysis of Actos (Pioglitazone) using Ascentis® Express C18

USP Analysis of Actos (Pioglitazone) using Ascentis® Express C18 application for HPLC

Matériaux

Colonne analytique

Réf. du produit
Description
Tarif

Ascentis® Express C18, 5 μm HPLC Column

5 μm particle size, L × I.D. 15 cm × 4.6 mm

Composant de phase mobile

Réf. du produit
Description
Tarif

Acétate d′ammonium

LiChropur, eluent additive for LC-MS

Étalon

Réf. du produit
Description
Tarif

Benzophénone

ReagentPlus®, 99%

Pioglitazone hydrochloride

United States Pharmacopeia (USP) Reference Standard

CONDITIONS

column

Ascentis® Express C18, 15 cm x 4.6 mm, 5 μm particles (50537-U)

mobile phase

[A] 100 mM ammonium acetate; [B] acetonitrile; [C] acetic acid; (55:45:2, A:B:C)

flow rate

0.7 mL/min

pressure

1160 psi (80 bar)

column temp.

25 °C

detector

UV, 269 nm

injection

20 μL

sample

pioglitazone 50 μg/mL, benzophenone 13 μg/mL in mobile phase

Description

Informations légales

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany